Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT05954611 | The Study of Single Dose Administration of GR2002 Injection in Chinese Health Volunteers | PHASE1 | COMPLETED | 50 | — | — | Jun 16, 2023 | Jan 2, 2024 | Aug 22, 2024 | 1 | China |
Incidence of AEs, including any abnormal physical examinations, abnormal vital signs, abnormal ECG, and abnormal lab testing
| Arm | Type | Description |
|---|---|---|
| GR2002 injection | EXPERIMENTAL | GR2002 subcutaneous injection |
| placebo | PLACEBO_COMPARATOR | placebo subcutaneous injection |
| Name | Type | Description |
|---|---|---|
| GR2002 injection | BIOLOGICAL | one single dose of GR2002 injection |
| Placebo | BIOLOGICAL | one single dose of placebo |
Inclusion Criteria: * 1\. Age of 18 to 55 years, inclusive, male or female 2. BMI between 19 kg/m2 and 26 kg/m2 (inclusive) 3. Healthy volunteers Exclusion Criteria: * 1\. History of chronic disease or serious disease 2. Subject with severe psychological or mental illness 3. Not enough washing-ou...